As a neuroscientist, Saad is interested in understanding how defects in GABAergic signaling underlie neurodevelopmental disorders. Saad routinely applies molecular neurobiology techniques such as electrophysiology, advanced cellular imaging and behavioral approaches to address questions of biological and clinical significance. His work at Harvard aims to address how interneurons develop, function and shape behavior during critical stages of brain development.
Prior to his appointment at Harvard, Saad graduated with a First Class from University College London and completed his PhD as a Dorothy Hodgkin Postgraduate Scholar. After his PhD, Saad was awarded multiple fellowships including a Rosetrees Trust Postdoctoral award, International Rett Syndrome Foundation fellowship and Wellcome Trust ISSF fellowship and has been a part of a large London-based consortium studying GABA inhibition in Down syndrome. Saad has published extensively on the molecular neuropharmacology and neurobiology of GABA receptors and inhibitory neurotransmission.